It takes teamwork to bring new treatments to cancer patients. Scientists, patients, and donors make it possible for us to create lifesaving therapies. Thanks to our community, we continue to fund groundbreaking scientific studies leading to the next great discoveries. We launch clinical trials that give patients new options and hope. And we bring all of us closer to a world free from the fear of cancer. Read more below about the important people behind the progress at the Cancer Research Institute.

Patients
Janie Ferling
Melanoma
When Janie, a mother from L.A., learned that a lump in her neck was malignant melanoma, she was determined to do whatever she could to be around as long as possible for her son.
Brenda Berchtold
Breast Cancer
When Brenda, 51, was first diagnosed with triple-negative breast cancer in 1986, her treatment options were limited. But much has changed since then, and Brenda is now receiving immunotherapy.
Judy Gray
Lung Cancer
When Judy, 68, was facing a diagnosis of stage 4 lung cancer, she took a predictably analytic approach to her treatment options and enrolled in a new immunotherapy clinical trial.
Emily Whitehead
Leukemia
At only 6-years-old, Emily faced a life-threatening recurrence of leukemia. Determined to save her life, her parents enrolled her in a clinical trial.
Marguerite Sullivan
Melanoma
Marguerite credits immunotherapy with allowing her to carry on with her normal life while also receiving the best care for her cancer, metastatic melanoma.
Brendan Connors
Melanoma
After successfully finishing a combination of immunotherapies for metastatic melanoma, 32-year-old Brendan seized any opportunity for adventure.
Don H.
Lung Cancer
When computer professional Don, 61, was facing a grim prognosis from chemo-resistant lung cancer, he did what came naturally: he took to Google to research his options and learned about immunotherapy.
Maureen O'Grady
Lung Cancer
In 2010, Maureen participated in a clinical trial of a new immunotherapy drug called nivolumab to treat her stage 4 lung cancer.
Bob Carlson
Lung Cancer
Because chemotherapy for his stage 4 lung cancer was a concern, Bob, 71, enrolled in an immunotherapy clinical trial.
Richard Catlett
Kidney Cancer
For 7 years, Richard endured round after round of treatment for kidney cancer, but it always came back. Then, in 2013, he enrolled in a clinical trial of nivolumab.
Lynn Luckeroth
Melanoma
Lynn is no stranger to cancer, having lost both her mother and her son to the disease. When she herself was diagnosed with melanoma, she looked to immunotherapy.
Gene Ogle
Pancreatic Cancer
When Gene learned he had pancreatic cancer, he was determined to spend more time with his grandchildren by enrolling in cancer immunotherapy clinical trials.
Sue Bohlin
Melanoma
Sue was free from breast cancer after a five-year battle, but she was diagnosed with a new, unrelated cancer two years later: melanoma.
John Yaryan
Prostate Cancer
When John, a 77-year-old Air Force veteran, was diagnosed with stage IV prostate cancer, he enrolled in a clinical trial to test the immunotherapy Yervoy.
Christine Sable
Ovarian Cancer
Ovarian cancer survivor Christine shares her powerful story of hope and perseverance in the face of "the cancer that whispers."
Scientists
James P. Allison, Ph.D.
The University of Texas at MD Anderson Cancer Center
CRI Scientific Advisory Council director James Allison explains why "taking the brakes off" T cells is a good way to fight cancer.
Ian H. Frazer, AC, FRS, FAA
The University of Queensland, Australia
The CRI Clinical Investigator is modest about his contribution to the development of the recently-announced breakthrough cervical cancer vaccine.
Carl H. June, M.D.
University of Pennsylvania
Pancreatic cancer patients will be enrolled in a clinical trial of a new immunotherapy that harnesses the immune system’s ability to fight pancreatic cancer.
Hyam I. Levitsky, M.D.
Johns Hopkins University
Dr. Levitsky is in a unique position to facilitate academic-industry partnerships that will advance the development of cancer immunotherapies.
Kunle Odunsi, M.D., Ph.D.
Roswell Park Cancer Institute
CRI physician-scientist Kunle Odunsi, M.D., Ph.D., is leading the way in cancer immunotherapy for ovarian cancer.
Corrie Painter, Ph.D.
University of Massachusetts
Angiosarcoma patient and CRI postdoctoral fellow Dr. Corrie Painter is studying how immune cells in zebrafish can fight against hers and other cancers.
David A. Reardon, M.D.
Dana-Farber Cancer Institute
For glioblastoma, the most dangerous and aggressive form of brain cancer, fewer than 10 percent of patients survive more than 5 years. Dr. Reardon wants to change that.
Antoni Ribas, M.D., Ph.D.
University of California, Los Angeles
Dr. Ribas, of UCLA, discusses his latest immunotherapy clinical trials and how it'll transform cancer treatment.
Robert Schreiber, Ph.D.
Washington University School of Medicine
By redefining our understanding of the relationship between cancer and the immune system, Dr. Robert Schreiber has brought us closer to cures for cancer
Padmanee Sharma, M.D., Ph.D.
The University of Texas at MD Anderson Cancer Center
Dr. Sharma's translational research focuses on learning how to apply immune-based therapeutic strategies to manipulate components of the human immune system to lead to tumor regression.
Ralph Steinman, M.D.
The Rockefeller University
Dr. Steinman discusses his pioneering research on the role of dendritic cells in the immune system's response to cancer.
Jedd D. Wolchok, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center
The leading immunotherapy expert knows better than almost anyone what clinical trials can do for patients.
Supporters
Let's spread the word about Immunotherapy! Click to share this page with your community.

*Immunotherapy results may vary from patient to patient.

Top